Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Get a Quote281 Reports in Cell Biology
Biomarker Deals: Terms, Value and Trends, 2008-2018
Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.
Chromatography in Pharmaceuticals and Biotechnology: Global Marke...
The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.
Cell-based Assays: Technologies and Global Markets
The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.
Proteomics: Technologies and Global Markets
The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Biomarkers: Technologies and Global Markets
The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Global Markets for Enzymes in Industrial Applications
The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Current Research & Developments Status of Chimeric Antigen Recept...
The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...
The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.
Microbial Products: Technologies, Applications and Global Markets
The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.
Synthetic Biology: Global Markets
The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.
Cardiac Biomarkers: Technologies and Global Markets
The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022
Digital Polymerase Chain Reaction (PCR) Technology: Global Market...
The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.
Exosome Diagnostics and Therapeutics: Global Markets
The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Artificial Blood: Global Markets to 2027
The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.
Biosimilars: Global Markets
The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.
Choose your License
2 Upcoming Reports in Cell Biology
DNA Data Storage: Global Markets and Technologies
This report provides an overview of the global markets and technologies for DNA data storage and analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025.
Biomarkers: Technologies and Global Markets
This report provides a comprehensive overview of the global market for biomarker technologies within the industry. Also, get the latest information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall marketplace.